Increased Intrarenal Arterial Stiffness May Predict the Occurrence of New Digital Ulcers in Systemic Sclerosis
|
|
- Garey Logan
- 5 years ago
- Views:
Transcription
1 Arthritis Care & Research Vol. 66, No. 9, September 2014, pp DOI /acr , American College of Rheumatology ORIGINAL ARTICLE Increased Intrarenal Arterial Stiffness May Predict the Occurrence of New Digital Ulcers in Systemic Sclerosis EDOARDO ROSATO, BIAGIO BARBANO, ANTONIETTA GIGANTE, ILENIA MOLINARO, SILVIA QUARTA, SIMONETTA PISARRI, ANTONIO AMOROSO, ROSARIO CIANCI, AND FELICE SALSANO Objective. Patients with systemic sclerosis (SSc; scleroderma) are at high risk for the development of ischemic digital ulcers (DUs), which occur in 35 60% of SSc patients. The aim of this study was to assess the correlation between intrarenal arterial stiffness and DUs in SSc patients and to evaluate the prognostic value of Doppler indices to predict new DU occurrence. Methods. Seventy unselected, consecutive patients with SSc (58 women and 12 men, mean SD age years) were enrolled. In all patients, Doppler ultrasound examination was performed. The following Doppler indices of intrarenal stiffness were measured: peak systolic velocity (PSV), end diastolic velocity (EDV), resistive index (RI), pulsatile index (PI), and systolic/diastolic ratio (S/D). Results. In total, 30 (42%) of 70 patients experienced new DUs. RI, S/D, and PI were significantly higher in SSc patients with new DUs than in SSc patients without new DUs. The receiver operating characteristic (ROC) curves demonstrated a good accuracy of new DU prediction for RI (0.94, P < ), S/D (0.92, P < ), and PI (0.88, P < ). Conversely, the ROC curve showed no performance for PSV (0.58, P > 0.05) and EDV (0.28, P > 0.05). Using a cutoff value of 0.70 for RI and 3.25 for S/D, the positive predictive value was 90.6% and 92.9%, respectively. Conclusion. We can conclude that Doppler indices of intrarenal stiffness are reliable markers of new DU occurrence. Doppler indices could be used in association with the capillaroscopic and clinical findings or serologic tests for the identification of patients at high risk of developing DUs. INTRODUCTION Systemic sclerosis (SSc; scleroderma) is an autoimmune disease characterized by endothelial dysfunction and fibrosis of the skin and internal organs. Endothelial dysfunction, microvascular damage, and macrovascular damage are the hallmarks of SSc (1,2). Patients with SSc are at high risk for the development of ischemic digital ulcers (DUs), which occur in 35 60% of SSc patients (3). The early detection of patients with a high risk of developing DUs could allow a preventive treatment of these complications, with a reduction of morbidity and social costs. The capillaroscopic skin ulcer risk index Edoardo Rosato, MD, PhD, Biagio Barbano, MD, Antonietta Gigante, MD, Ilenia Molinaro, MD, Silvia Quarta, MD, Simonetta Pisarri, MD, Antonio Amoroso, MD, Rosario Cianci, MD, Felice Salsano, MD: Sapienza University of Rome, Rome, Italy. Address correspondence to Edoardo Rosato, MD, PhD, Sapienza University of Rome, Department of Clinical Medicine, Clinical Immunology Unit, Viale dell Università 37, Rome, Italy. edoardo.rosato@uniromal.it. Submitted for publication June 3, 2013; accepted in revised form February 4, (CSURI) may represent a novel tool with the ability to predict the development of DUs in SSc patients (4). Chronic renal vasculopathy is frequent in SSc patients, while scleroderma renal crisis (SRC) has been reported in 10% of SSc patients. Increased arterial stiffness is known to be associated with sclerodermic kidney dysfunction. It is known that Doppler renal ultrasound is a useful and noninvasive diagnostic tool to evaluate intrarenal arterial stiffness. In SSc patients, renal Doppler ultrasound is especially useful in both subclinical renal damage and SRC (5). Rosato et al demonstrated that intrarenal hemodynamic parameters correlate with glomerular filtration rate (GFR) and digital microvascular damage in SSc (6). Moreover, the indices are also useful in monitoring SRC and evaluating the response to specific drugs (7). The aim of this study was to asses a correlation between intrarenal arterial stiffness and DUs in SSc patients and to evaluate the prognostic value of Doppler indices to predict new DU occurrence. SUBJECTS AND METHODS Subjects. Enrolled in this study were 70 consecutive patients with SSc (58 women and 12 men, mean SD ages 1380
2 Intrarenal Arterial Stiffness and Digital Ulcers 1381 Significance & Innovations Doppler indices of intrarenal arterial stiffness were increased in patients with systemic sclerosis. Doppler indices of intrarenal arterial stiffness were higher in systemic sclerosis patients with digital ulcers than in systemic sclerosis patients without digital ulcers. Doppler indices of intrarenal stiffness were reliable markers of new digital ulcer occurrence. Table 1. Epidemiologic and clinical features of the SSc patients* Value Sex, men/women 58/12 Age, years Disease duration, years Raynaud s phenomenon duration, years dcssc/lcssc 39/31 SSc-specific autoantibodies, no. (%) Anti topoisomerase I 38 (54) Anticentromere 25 (36) None 7 (10) Patients with digital ulcer history, no. (%) 46 (65) Patients with new digital skin ulcers, no. (%) 30 (42) No. of digital ulcers/patient Capillaroscopic pattern, no. (%) Early 27 (38.6) Active 25 (35.7) Late 18 (25.7) * Values are the mean SD unless indicated otherwise. SSc systemic sclerosis; dcssc diffuse cutaneous SSc; lcssc limited cutaneous SSc years). All patients met the preliminary American College of Rheumatology criteria for the classification of SSc (8). The mean SD duration of Raynaud s phenomenon (RP) and mean SD duration of disease were years and years, respectively. Overall, 31 patients had limited cutaneous SSc (lcssc) and 39 had diffuse cutaneous SSc (dcssc), as defined by LeRoy et al (9). Table 1 shows the epidemiologic and clinical features of the SSc patients. Patients with obstructive kidney disease and renal artery stenosis and those with microscopic or macroscopic hematuria, abnormal urinary sediment, SRC, history of glomerulonephritis or nephroureterolithiasis, antiphospholipid-associated nephropathy, coexistent myeloperoxidase antineutrophil cytoplasmic autoantibody associated glomerulonephritis, dilated renal pelvis or atrophied kidney on ultrasonography, overt proteinuria, or elevated serum creatinine concentration ( 106 moles/liter) were excluded. Patients with a history of uncontrolled systemic hypertension, hyperlipidemia, cardiac failure, cardiac valve diseases (insufficiency or stenosis of aortic and mitralic valve), hepatic failure, diabetes mellitus, cerebrovascular diseases, peripheral vascular diseases, and coagulopathy were excluded, and smokers and pregnant or breastfeeding women were also excluded. All SSc patients underwent treatment with calciumchannel blockers (nifedipine 30 mg/day). At the time of Doppler examination, 27 patients were receiving prostanoid therapy and 18 were receiving bosentan. No studies have demonstrated an influence of bosentan on Doppler indices of interlobar arteries. Our data did not show any influence of bosentan on intrarenal Doppler indices. None of the patients were treated with immunosuppressive agents (e.g., cyclophosphamide or mycophenolate mofetil). After Doppler examination, the patients were examined for the appearance of new DUs after 3, 6, 9, and 12 months of followup without any changes in previous treatments. Thirty healthy controls were also recruited (26 women and 4 men, mean SD ages years). The subjects written consent was obtained according to the Declaration of Helsinki and the study was approved by the Ethics Committee of Sapienza University. Doppler ultrasound. SSc patients and healthy controls were placed for at least 15 minutes before the Doppler ultrasound examination in a temperature-controlled room at C. The size of the left and right kidneys and the flow in the aorta and renal arteries were evaluated to detect a morphologic abnormality or renal artery stenosis. During the measurements, the patients were supine and held their breath. Doppler ultrasound examinations were performed by the same senior nephrologist blinded to the clinical features of the patient (RC). Renal Doppler ultrasound was performed using a Toshiba Aplio Ultrasound System SSA- 790 equipped with a convex 3.5-MHz probe. Renal Doppler flow was obtained in 3 different interlobar arteries of both kidneys (mesorenal, superior, and inferior pole), guided by color-flow mapping. The Doppler gate width was kept small, and the angle of insonation was maintained at 60. We used an anterior approach for detecting the renal artery origin and an oblique, lateral approach for the intermediate tract and intrarenal vessels. No aliasing was allowed in the interlobar arteries while the following parameters were measured: peak systolic velocity (PSV), end diastolic velocity (EDV), resistive index (RI), pulsatile index (PI), and systolic/diastolic ratio (S/D). RI was calculated as (peak systolic frequency shift minimum diastolic frequency shift)/peak systolic frequency shift and the PI was calculated as (peak systolic frequency shift minimum diastolic frequency shift)/mean frequency shift. The PSV and EDV are expressed as cm/second. The mean value of 3 measurements of interlobar arteries from each kidney was calculated. For each patient, Doppler ultrasound parameters were calculated as the mean of measurements of both kidneys. While performing the renal Doppler examination, the operator evaluated the heart function. The Doppler examination was not performed in SSc patients and healthy controls with arrhythmia or tachycardia or bradycardia. Weighted kappa was used to evaluate the intrarater reliability by the same observer. The kappa values for RI and S/D were and 0.965, respectively. The intrapatient
3 1382 Rosato et al Table 2. Doppler indices of SSc patients and healthy controls* SSc patients Healthy controls PSV, cm/second EDV, cm/second PI RI S/D * Values are the mean SD. SSc systemic sclerosis; PSV peak systolic velocity; EDV end diastolic velocity; PI pulsatile index; RI resistive index; S/D systolic/diastolic ratio. coefficient of variation for RI and S/D measurement was 1.2% and 1.3%, respectively. Calcium-channel blocker therapy was discontinued 72 hours before the Doppler ultrasound. Patients receiving iloprost therapy underwent Doppler examination the day before the next infusion (6,7). Estimated GFR. According to a previous study, GFR was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation, which expressed as a single equation is GFR 141 min(serum creatinine/, 1) max (serum creatinine/, 1) Age (if female) (if black), where 0.7 for females and 0.9 for males, for females and for males, and min indicates the minimum of serum creatinine/ or 1 and max indicates the maximum of serum creatinine/ or 1 (10). Nailfold videocapillaroscopy (NVC). NVC was performed with a videocapillaroscope (Pinnacle Studio Version 8) equipped with a 500 optical probe. The nailfold of the second, third, fourth, and fifth finger was examined in each patient. According to Cutolo et al, the patterns identified within the SSc pattern included early, active, and late (11). DUs. The DUs were classified according to Amanzi et al as follows: DUs derived from digital pitting scar (DPS), pure DUs, DUs derived from calcinosis, and DUs derived from gangrene (12). Statistical analysis. All of the results were expressed as the mean and SD. Commercial software (SPSS, version P 20.0) was used for statistical analysis. The coefficient of skewness and the coefficient of kurtosis were used to evaluate normal distribution of data. Multivariate analysis was applied for the estimation of the relationship of Doppler indices with clinical features (e.g., age and duration of disease). A receiver operating characteristic (ROC) curve analysis was performed to analyze the prognostic accuracy of each Doppler index in regard to ulcer development. Group comparisons were made by Student s unpaired 2-tailed t-test. Pearson s product-moment correlation coefficient (r) was used to test for an association between numerical variables. Chi-square test or Fisher s exact test, as appropriate, was used to compare categorical variables. Relative risk (RR) and 95% confidence intervals (95% CIs) are reported. Comparisons between the 3 NVC patterns were by nonparametric Kruskal-Wallis test and the data were expressed as the median and range. P values less than 0.05 were considered significant. RESULTS PSV did not show a significant difference (P 0.05) between SSc patients and healthy controls (mean SD versus cm/second). EDV was significantly (P 0.001) lower in SSc patients than healthy controls (mean SD versus cm/second). PI (mean SD versus ), RI (mean SD versus ), and S/D (mean SD versus ) were significantly higher in SSc patients than in healthy controls (Table 2). In SSc patients, no statistical correlations were observed between Doppler indices (PSV, EDV, RI, PI, and S/D) and age, subset of disease, and SSc-specific autoantibodies. PSV, EDV, and PI showed no statistically significant (P 0.05) correlation with estimated GFR. Estimated GFR was correlated with other Doppler indices, including RI (r 0.31, P 0.01) and S/D (r 0.35, P 0.01). In 3 capillaroscopic groups of SSc patients, no significant differences of PSV and EDV were observed. PI, RI, and S/D significantly increased with the progression of capillaroscopic damage (Table 3). The principal features of SSc patients with or without new DUs are shown in Table 4. Within 12 months since the Doppler ultrasound, 30 (42%) of 70 patients experienced new DUs. The new DUs were more frequent (P 0.05) in patients with dcssc (30%) than in patients with lcssc (12.9%). The occurrence of new DUs was higher Table 3. Doppler indices of 3 capillaroscopic groups* Healthy controls, mean SD Early Active Late P PSV, cm/second ( ) 32.6 ( ) 33 ( ) 0.05 EDV, cm/second ( ) 10.6 ( ) 8.5 ( ) 0.05 PI ( ) 1.33 ( ) 1.67 ( ) RI ( ) 0.69 ( ) 0.73 ( ) S/D ( ) 3.23 ( ) 3.71 ( ) * Values are the median (range) unless otherwise indicated. P was calculated in 3 capillaroscopic patterns. PSV peak systolic velocity; EDV end diastolic velocity; PI pulsatile index; RI resistive index; S/D systolic/diastolic ratio.
4 Intrarenal Arterial Stiffness and Digital Ulcers 1383 Table 4. Clinical features of SSc patients with or without new DUs* Patients with new DUs Patients without new DUs DU history Yes 29 (41.4) 17 (24.3) No 1 (1.4) 23 (32.9) Subset dcssc 21 (30.0) 18 (25.7) lcssc 9 (12.9) 22 (31.4) Autoantibodies Anti topoisomerase I 19 (27.1) 18 (25.7) Others 11 (15.7) 22 (31.4) Capillaroscopy Early 1 (1.4) 26 (37.1) Active 14 (20.0) 11 (15.7) Late 15 (21.4) 3 (4.3) * Values are the number (percentage). SSc systemic sclerosis; DUs digital ulcers; dcssc diffuse cutaneous SSc; lcssc limited cutaneous SSc. (P 0.05) in patients with anti topoisomerase I antibodies (27.1%) than in patients with other autoantibodies (15.7%). The new DU occurrence was higher (P ) in SSc patients with DU history (41.4%) than in SSc patients without DU history (1.4%). New DUs were more frequent (P ) in patients with active and late capillaroscopic pattern than in patients with early capillaroscopic pattern (Table 4). We observed 119 new DUs in SSc patients: 52 DPS (43.7%), 62 pure DUs (52.1%), 4 DUs derived from calcinosis (3.4%), and 1 DU derived from gangrene (0.8%). We did not observe any correlation between DU subset and intrarenal Doppler indices. For treatments, 2 (66.6%) of 3 patients treated with bosentan developed new DUs, 6 (50%) of 12 patients treated with intravenous iloprost developed new DUs, and 11 (73%) of 15 patients treated with bosentan and intravenous iloprost developed new DUs. When comparing patients with and without new DUs, we observed significant differences in many Doppler indices; RI, S/D, and PI were significantly higher in SSc patients with new DUs than in SSc patients without new DUs. Therefore the PI, RI, and S/D were significantly (P ) higher in SSc patients without DUs than healthy controls (Table 5). RI (mean SD versus ), S/D (mean SD versus ), and PI (mean SD versus ) were significantly (P ) higher in SSc patients with DU history than in SSc patients without DU history. No significant differences of PSV and EDV were observed in SSc patients with DU history and without DU history. The ROC curves demonstrated a good accuracy of new DU prediction for RI (0.94, P [95% CI ]), S/D (0.92, P [95% CI ]), and PI (0.88, P [95% CI ]). Conversely, the ROC curve showed no performance for PSV (0.58, P 0.05 [95% CI ]) and EDV (0.28, P 0.05 [95% CI ]). Using a cutoff value of 0.70, the positive predictive value of RI was 90.6% (95% CI %). An RI 0.70 was present in 27 of 30 patients with new DUs. The negative predictive value was 92.8% (95% CI %), and only 3 of 42 patients with an RI 0.70 experienced new DUs. The association between new DUs and RI was confirmed by RR calculation (13.5 [95% CI ], P ). Using a cutoff value of 3.25, the positive predictive value of S/D was 92.9% (95% CI %). An S/D 3.25 was present in 26 of 30 patients with new DUs. The negative predictive value was 90.58% (95% CI %), and only 4 of 42 patients with an S/D 3.25 experienced new DUs. The association between new DUs and S/D was confirmed by RR calculation (17.3 [95% CI ], P ). DISCUSSION In this study, we demonstrated that intrarenal arterial stiffness was increased in SSc patients and was correlated with capillaroscopic damage. Additionally, estimated GFR correlated with some Doppler indices (RI and S/D). Conversely, the SSc patients with increased intrarenal stiffness showed an increased risk of DU occurrence. Previous studies have shown that chronic renal vasculopathy seems to be the main pathogenic mechanism of all SSc renal manifestations, including SRC. In the early stage of SSc renal damage, resistance indices increase and GFR is normal or slightly reduced. This initial reduction of GFR is linked more with a reduced blood inflow in intrarenal vessels than with a reduced glomerular filtration capacity. With the progression of intrarenal vascular damage, GFR is further reduced. In the late stage, the deterioration of GFR is due to both the further reduction of blood inflow of intrarenal arteries and the glomerular injury (6,7,13). Table 5. Doppler indices of SSc patients with or without new DUs* SSc patients with new DUs (n 30) SSc patients without new DUs (n 40) P PSV, cm/second EDV, cm/second PI RI S/D * Values are the mean SD. SSc systemic sclerosis; DUs digital ulcers; PSV peak systolic velocity; EDV end diastolic velocity; PI pulsatile index; RI resistive index; S/D systolic/diastolic ratio.
5 1384 Rosato et al Many of the severe internal organ complications of SSc are vascular. Intimal hyperplasia, endothelial dysfunction, and occlusive vasculopathy are ubiquitous features of SSc. These vascular lesions are the underlying basis of important clinical syndromes in SSc, including RP, DUs, pulmonary arterial hypertension, and SRC (14,15). The DU pathogenesis is believed to include many of the hallmark processes of critical tissue ischemia, such as impaired afferent vasomotion, endothelial dysfunction, microvascular disruption, intimal hyperplasia, reduced venous drainage, increased local platelet activation, and increased leukocyte adherence. Endothelin 1 (ET-1) showed a key role in the pathogenesis of SSc-associated DUs. Plasma ET-1 concentrations are increased in patients with SSc. Previous randomized, double-blind, placebocontrolled trials demonstrated that bosentan, an oral ET receptor antagonist, reduced new DU occurrence (3). Patients with SSc are at high risk for the development of ischemic DUs, which occur in 35 60% of patients with SSc. In our study groups, the incidence of new DUs was 42%. Our data do not differ much from those of the study by Steen et al. The majority (58%) of the 2,080 Pittsburgh patients had experienced a DU during their course of SSc, and one-third (32%) of all patients with SSc have had persistent DUs (persistent or recurrent ulcers for at least 6 months). However, no serologic or clinical markers have been proven safe in predicting the new DU occurrence. Many authors have tried to identify markers that may be predictive for the development of new DUs (16). The early occurrence and high frequency of DU complications are especially seen in patients with dcssc and/or antitopoisomerase antibodies. Male patients with early onset SSc, more severe skin fibrosis, impaired diffusing capacity for carbon monoxide, and anti topoisomerase I are most likely to exhibit prior or current DUs (17,18). Avouac et al identified high placental growth factor serum levels and low circulating endothelial progenitor cell counts as predictors of new DUs in SSc. This highlights the critical role of angiogenesis in this vascular outcome. These markers may improve DU risk stratification and therefore allow earlier therapeutic intervention (19). DU occurrence was associated with capillaroscopic damage. Cutolo et al demonstrated that skin DUs seemed to be associated with the late NVC pattern, characterized by avascular areas (severe capillary loss) (20). Sebastiani et al demonstrated that the proposed CSURI may represent a novel tool with the ability to predict the development of DUs in SSc patients. The development and validation of new outcome measures may facilitate the recognition of patients at high risk of developing DUs and may improve the monitoring of vascular complications and treatments (4). In our study group, Doppler indices (RI, S/D, and PI) were increased in SSc patients with new DUs compared to patients without new DUs. In addition, the subclinical renal vasculopathy seemed correlated to digital vascular damage; in fact, estimated GFR correlated with RI and S/D. Doppler indices of intrarenal arterial stiffness, particularly RI, showed a good accuracy of new DU predictions. Indeed, RI, S/D, and PI showed a good association with new DU occurrence. Ultrasound plays a crucial role in the assessment of organ involvement in SSc and vasculitides. Ultrasound measures promise reproducible and objective scores of disease activity and extension. Ultrasound reveals early pathognomonic abnormalities and may help start early treatment (21). The color Doppler measurement of RI at the level of the interlobar artery has been proposed as an indicator for differential diagnosis between acute and chronic nephropathies; for example, the ratio was higher in acute pathologies with vascular and tubulointerstitial involvement, but not in those with glomerular involvement. RI and S/D were advanced as useful parameters for quantifying the alterations in renal blood flow that may occur with renal disease (22). In lupus nephritis, RI correlated significantly with creatinine level, chronicity index, and presence of interstitial disease. Only RI and chronicity index were statistically significant predictors of a poor renal outcome (23). We can suppose that intrarenal stiffness is a manifestation of microvascular and vascular damage in SSc patients. Previous studies have demonstrated a correlation between microvascular digital damage and renal vascular damage (6). In addition, response to vasodilatator drugs correlated with intrarenal arterial Doppler indices (24,25). Because Doppler indices are an easy tool to use, we can assume that they could be used in association with the capillaroscopic and clinical findings or serologic tests in the identification of patients at high risk of developing DUs. We can conclude that Doppler indices of intrarenal stiffness are reliable markers of new DU occurrence. Therefore, larger studies are needed to confirm our preliminary data. AUTHOR CONTRIBUTIONS All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Dr. Rosato had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study conception and design. Rosato, Barbano, Gigante, Pisarri, Amoroso, Cianci, Salsano. Acquisition of data. Rosato, Barbano, Gigante, Molinaro, Quarta. Analysis and interpretation of data. Rosato, Barbano, Gigante, Molinaro, Quarta, Pisarri, Amoroso, Cianci, Salsano. REFERENCES 1. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4: Rosato E, Gigante A, Barbano B, Cianci R, Molinaro I, Pisarri S, et al. In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage. Microvasc Res 2011;82: Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 2011; 70: Sebastiani M, Manfredi A, Colaci M, D Amico R, Malagoli V, Giuggioli D, et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009;61:
6 Intrarenal Arterial Stiffness and Digital Ulcers Shanmugam VK, Steen VD. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol 2012;24: Rosato E, Gigante A, Barbano B, Cianci R, Molinaro I, Rossi C, et al. Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis. Semin Arthritis Rheum 2012;41: Rosato E, Gigante A, Barbano B, Molinaro I, Cianci R, Salsano F. Doppler indices of intrarenal arterial stiffness are useful in monitoring scleroderma renal crisis [letter]. Scand J Rheumatol 2013;42: Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23: LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998;15: Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases: a future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) 2006;45 Suppl 4: Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 2010;49: Gigante A, Rosato E, Massa R, Rossi C, Barbano B, Cianci R, et al. Evaluation of Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in scleroderma patients. Rheumatology (Oxford) 2012;51: Guiducci S, Giacomelli R, Cerinic MM. Vascular complications of scleroderma. Autoimmun Rev 2007;6: Matucci-Cerinic M, Kahaleh B, Wigley FM. Evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013;65: Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 2009;48 Suppl 3: Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Ann Rheum Dis 2012;71: Tiev KP, Diot E, Clerson P, Dupuis-Simeon F, Hachulla E, Hatron PY, et al. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: posthoc analysis of a nationwide multicenter cohort (ItinérAIR- Sclérodermie). J Rheumatol 2009;36: Avouac J, Meune C, Ruiz B, Couraud PO, Uzan G, Boileau C, et al. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Ann Rheum Dis 2012;71: Cutolo M, Sulli A, Pizzorni C, Smith V. Capillaroscopy as an outcome measure for clinical trials on the peripheral vasculopathy in SSc: is it useful? Int J Rheumatol 2010;2010: Porta F, Gargani L, Kaloudi O, Schmidt WA, Picano E, Damjanov N, et al. The new frontiers of ultrasound in the complex world of vasculitides and scleroderma. Rheumatology (Oxford) 2012;51 Suppl 7: Tublin ME, Bude RO, Platt JF. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 2003;180: Platt JF, Rubin JM, Ellis JH. Lupus nephritis: predictive value of conventional and Doppler US and comparison with serologic and biopsy parameters. Radiology 1997;203: Rosato E, Cianci R, Barbano B, Menghi G, Gigante A, Rossi C, et al. N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis. Acta Pharmacol Sin 2009;30: Rivolta R, Mascagni B, Berruti V, Quarto Di Palo F, Elli A, Scorza R, et al. Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy. Arthritis Rheum 1996;39:
Peripheral (digital) vasculopathy in systemic. sclerosis. Ariane Herrick
Peripheral (digital) vasculopathy in systemic sclerosis Ariane Herrick Raynaud s phenomenon VASOPASM DEOXYGENATION REPERFUSION Main causes of RP Primary (idiopathic) Connective tissue diseases, including
More informationSecondary Raynaud s Phenomenon
Secondary Raynaud s Phenomenon Ulf Müller-Ladner University of Giessen Kerckhoff Clinic Bad Nauheim Germany Clinical problems in SSc Therapeutic solutions? Pulmonary fibrosis + PAH Diffuse Pulmonary fibrosis,
More informationNon-commercial use only
ORIGINAL Reumatismo, 2013; 65 (4): 186-191 Prospective capillaroscopy-based study on transition from primary to secondary Raynaud s phenomenon: preliminary results E. Bernero, A. Sulli, G. Ferrari, F.
More informationSupplementary Online Content
Supplementary Online Content Caglayan E, Axmann S, Hellmich M, Moinzadeh P, Rosenkranz S. Vardenafil for the treatment of Raynaud phenomenon: a randomized, double-blind, placebocontrolled crossover study.
More informationSuccessful Treatment of Newly Developed, Intractable Digital Ulcers and Gangrene with Bosentan in Systemic Sclerosis
Journal of Rheumatic Diseases Vol. 23, No. 3, June, 2016 http://dx.doi.org/10.4078/jrd.2016.23.3.193 Case Report Successful Treatment of Newly Developed, Intractable Digital Ulcers and Gangrene with Bosentan
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/188/35226 holds various files of this Leiden University dissertation Author: Meijs, Jessica Title: Systemic sclerosis : from science to clinical practice Issue
More informationPoints to consider for skin ulcers in systemic sclerosis
RHEUMATOLOGY Rheumatology 2017;56:v67 v71 doi:10.1093/rheumatology/kex200 Points to consider for skin ulcers in systemic sclerosis Felice Galluccio 1, Yannick Allanore 2,Lázló Czirjak 3, Daniel E. Furst
More informationReview Article Registry Evaluation of Digital Ulcers in Systemic Sclerosis
Hindawi Publishing Corporation International Journal of Rheumatology Volume 2010, Article ID 363679, 5 pages doi:10.1155/2010/363679 Review Article Registry Evaluation of Digital Ulcers in Systemic Sclerosis
More informationReliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study Vanessa Smith, 1 Carmen Pizzorni, 2 Filip De Keyser, 1 Saskia
More informationComparison of qualitative and quantitative analysis of capillaroscopic findings in patients with rheumatic diseases
DOI 10.1007/s00296-011-2222-2 ORIGINAL ARTICLE Comparison of qualitative and quantitative analysis of capillaroscopic findings in patients with rheumatic diseases Sevdalina Nikolova Lambova Walter Hermann
More information8 th EULAR Course on Capillaroscopy in Rheumatic Diseases
8 th EULAR Course on Capillaroscopy in Rheumatic Diseases 13 th -15 th September, 2018 Genova, Italy eular.org ORGANISATION AND COMMITTEE Scientific Organiser Maurizio Cutolo, MD Director Research Laboratory
More informationThe Journal of Rheumatology Volume 43, no. 11
The Volume 43, no. 11 Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis Amelia Chiara
More informationNailfold Capillary Density is Associated with the Presence and Severity of Pulmonary Arterial Hypertension in Systemic Sclerosis
4 Nailfold Capillary Density is Associated with the Presence and Severity of Pulmonary Arterial Hypertension in Systemic Sclerosis Herman M.A. Hofstee, Anton Vonk Noordegraaf, Alexandre e. Voskuyl, Ben
More informationPredictors of Isolated Pulmonary Hypertension in Patients With Systemic Sclerosis and Limited Cutaneous Involvement
ARTHRITIS & RHEUMATISM Vol. 48, No. 2, February 2003, pp 516 522 DOI 10.1002/art.10775 2003, American College of Rheumatology Predictors of Isolated Pulmonary Hypertension in Patients With Systemic Sclerosis
More informationDigital ulcers: overt vascular disease in systemic sclerosis
Rheumatology 2009;48:iii19 iii24 doi:10.1093/rheumatology/kep105 Digital ulcers: overt vascular disease in systemic sclerosis V. Steen 1, C. P. Denton 2, J. E. Pope 3 and M. Matucci-Cerinic 4 RP is an
More informationAssessment of capillary density in systemic sclerosis with three different capillaroscopic methods
Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods M. Wildt, D.M. Wuttge, R. Hesselstrand, A. Scheja Department of Clinical Science, Division of Rheumatology,
More informationScleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Edward Dwyer, M.D. Division of Rheumatology
Scleroderma Edward Dwyer, M.D. Division of Rheumatology Nomenclature Synonyms Scleroderma Progressive Systemic Sclerosis Systemic Sclerosis Scleroderma 1 Scleroderma Chronic systemic autoimmune disease
More informationScleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Limited vs. Diffuse Scleroderma.
Scleroderma Edward Dwyer, M.D. Division of Rheumatology Nomenclature Synonyms Scleroderma Progressive Systemic Sclerosis Systemic Sclerosis Scleroderma Chronic systemic autoimmune disease characterized
More informationNon-commercial use only
ORIGINAL Reumatismo, 2013; 65 (6): 286-291 Efficacy of bosentan in the treatment of Raynaud s phenomenon in patients with systemic sclerosis never treated with prostanoids S. Parisi, M. Bruzzone, C. Centanaro
More informationNailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis
Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis C. Kayser, J.Y. Sekiyama, L.C. Próspero, C.Z. Camargo, L.E.C. Andrade Rheumatology Division, Universidade
More informationPrediction of Tubulo Interstitial Injuries by Doppler Ultrasound in Patients with Glomerular Disease: Value of Resistive Index and Atrophic Index
International Journal of Scientific and Research Publications, Volume 5, Issue 8, August 2015 1 Prediction of Tubulo Interstitial Injuries by Doppler Ultrasound in Patients with Glomerular Disease: Value
More informationDysfunctional arteriovenous anastomoses in the hands of systemic sclerosis patients with digital ulcers
Dysfunctional arteriovenous anastomoses in the hands of systemic sclerosis patients with digital ulcers T.K. Bergersen 1, A.-M. Hoffmann-Vold 2, Ø. Midtvedt 2, J.T. Gran 2, C. Mørk 3, K. Toska 4, M. Elstad
More informationSCLERODERMA 101. Maureen D. Mayes, MD, MPH Professor of Medicine University of Texas - Houston
SCLERODERMA 101 Maureen D. Mayes, MD, MPH Professor of Medicine University of Texas - Houston TYPES OF SCLERODERMA Localized versus Systemic Two Kinds of Scleroderma Localized Scleroderma Morphea Linear
More informationBSR and BHPR guideline for the treatment of systemic sclerosis
BSR and BHPR guideline for the treatment of systemic sclerosis Christopher P. Denton, Michael Hughes, Nataliya Gak, Josephine Vila, Maya Buch, Kuntal Chakravarty, Kim Fligelstone, Luke L Gompels, Bridget
More informationSCLERODERMA RENAL CRISIS. Presented by : Nouf Alanazi
SCLERODERMA RENAL CRISIS Presented by : Nouf Alanazi Agenda Prevalence Risk factors Pathology Diagnosis Prevention & monitoring Treatment Outcome & mortality. Summary & recommendations References SRC Abrupt
More informationNailfold Capillaroscopic Abnormalities in Connective Tissue Disease-associated Pulmonary Arterial Hypertension are Not Specific for Systemic Sclerosis
Nailfold Capillaroscopic Abnormalities in Connective Tissue Disease-associated Pulmonary Arterial Hypertension are Not Specific for Systemic Sclerosis Herman M.A. Hofstee, erik H. Serné, yvo M. Smulders,
More informationManagement of scleroderma renal crisis. Voon Ong Senior Clinical Lecturer Royal Free Hospital and UCL Medical School, London, UK
Management of scleroderma renal crisis Voon Ong Senior Clinical Lecturer Royal Free Hospital and UCL Medical School, London, UK Overview Presentation of SRC Diagnosis and management Pathogenesis Predictors
More informationTransducer Selection. Renal Artery Duplex Exam. Renal Scan. Renal Scan Echogenicity. How to Perform an Optimal Renal Artery Doppler Examination
How to Perform an Optimal Renal Artery Doppler Examination Director of Ultrasound Education & Quality Assurance Baylor College of Medicine Division of Maternal-Fetal Medicine Maternal Fetal Center Imaging
More informationこの論文は出版社版でありません 引用の際には出版社版をご確認ご利用ください This is not the publis version. Please cite only the publi
Title A case of progressive digital ische gemcitabine and S-1 in a patient wi Zaima, C; Kanai, M; Ishikawa, S; Ka Author(s) Mori, Y; Nishimura, T; Matsumoto, S T; Mimori, T Citation Japanese journal of
More informationReliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis
Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis M. Hudson, A. Masetto, R. Steele, E. Arthurs, M. Baron for the Canadian Scleroderma Research Group*
More informationDocSpot what patients want to know
DocSpot what patients want to know Professor Chris Denton Royal Free Hospital London, UK Madrid, February 2012 Copyright 2011 Raynaud's & Scleroderma Association. Charity Reg. No. 326306 DocSpot Live!
More informationScleroderma and PAH Overview. PH Resource Network Martha Kingman, FNP C UTSW Medical Center at Dallas
Scleroderma and PAH Overview PH Resource Network 2007 Martha Kingman, FNP C UTSW Medical Center at Dallas Scleroderma and PAH Outline: Lung involvement in scleroderma Evaluation of the scleroderma patient
More informationUpdate in Systemic Sclerosis! Lauren Kim MD! NW Rheumatology Associates
Update in Systemic Sclerosis! Lauren Kim MD! NW Rheumatology Associates Review Systemic sclerosis affects approximately 75,000 to 100,000 people in the U.S. and has the highest mortality rate of any autoimmune
More informationExercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables
Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables E. Rosato 1, A. Romaniello 2, D. Magrì 2, M. Bonini 3, L. Sardo 1, A. Gigante 1, S. Quarta
More informationDigital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud s phenomenon and systemic sclerosis
Rheumatology 2002;41:324 328 Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud s phenomenon and systemic sclerosis M. E. Anderson, T. L.
More informationDisclosures. Scleroderma: Early Diagnosis How early is early? 10/28/2013. Difficult Scleroderma: How do I Approach this Patient?
Disclosures Financial support: None Difficult Scleroderma: How do I Approach this Patient? Francesco Boin, MD Assistant Professor of Medicine Director, Translational Research Johns Hopkins Scleroderma
More informationAbnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis
Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis V. Riccieri, K. Stefanantoni, M. Vasile, V. Macrì, I.
More informationTitle: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy
Author's response to reviews Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Authors: Nan Zhen Dong (dongzn@301hospital.com.cn) Yong
More informationClinical Commissioning Policy: Sildenafil and Bosentan for the Treatment of Digital Ulceration in Systemic Sclerosis
Clinical Commissioning Policy: Sildenafil and Bosentan for the Treatment of Digital Ulceration in Systemic Sclerosis Reference: NHS England: A13/P/b NHS England INFORMATION READER BOX Directorate Medical
More informationHaving a stem cell transplant for scleroderma a patient and doctor perspective
Having a stem cell transplant for scleroderma a patient and doctor perspective Professor Chris Denton, On behalf of an excellent team across UCLPartners Royal Free Hospital and University College London,
More informationDigital Ulcers in Systemic Sclerosis
ARTHRITIS & RHEUMATISM Vol. 50, No. 12, December 2004, pp 3985 3993 DOI 10.1002/art.20676 2004, American College of Rheumatology Digital Ulcers in Systemic Sclerosis Prevention by Treatment With Bosentan,
More informationAbsence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud s Phenomenon
Bissell et al. BMC Musculoskeletal Disorders (2016) 17:342 DOI 10.1186/s12891-016-1206-5 RESEARCH ARTICLE Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma
More informationDisease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group
Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group P. Airò, M. Rossi 1, M. Scarsi, E. Danieli, A. Grottolo
More informationRADIOLOGY HEAD & NECK IMAGING. Iranian Journal of. Hadi Rokni Yazdi 1*, Safoura Faraji 2, Farokhlegha Ahmadi 3, Reza Shahmirzae 4
HEAD & NECK IMAGING Iran J Radiol. 2012;9(1):12-16. DOI: 10.5812/iranjradiol.6730 Iranian Journal of RADIOLOGY RADIOLOGYwww.iranjradiol.com Color Doppler Indices of Orbital Arterial Flow in End-Stage Renal
More informationMicrovascular Changes in Patients with Psoriatic Arthritis as Shown in Nail Fold Capillaroscopy
International Journal of Sciences: Basic and Applied Research (IJSBAR) ISSN 2307-4531 (Print & Online) http://gssrr.org/index.php?journal=journalofbasicandapplied ---------------------------------------------------------------------------------------------------------------------------
More informationRECENT ADVANCES IN THE PATHOGENESIS AND MANAGEMENT OF RAYNAUD'S PHENOMENON AND
RECENT ADVANCES IN THE PATHOGENESIS AND MANAGEMENT OF RAYNAUD'S PHENOMENON AND DIGITAL ULCERS Ariane L Herrick, MD, Centre for Musculoskeletal Research, The University of Manchester, Salford Royal NHS
More informationSEVERE ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS WITH DIFFUSE SCLERODERMA
ARTHRITIS & RHEUMATISM Vol. 43, No. 11, November 2000, pp 2437 2444 2000, American College of Rheumatology 2437 SEVERE ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS WITH DIFFUSE SCLERODERMA VIRGINIA D. STEEN
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationTRANSPARENCY COMMITTEE OPINION. 23 January 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 23 January 2008 TRACLEER 62.5 mg film-coated tablets Pack of 56 (CIP: 563 621-1) TRACLEER 125 mg film-coated tablets
More informationLupus as a risk factor for cardiovascular disease
Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo
More informationUNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS
UNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS CanVasc meeting Montreal Nov 22 2012 Patrick Liang Service de rhumatologie Centre Hospitalier Universitaire
More informationGoals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound
Access flow and renal artery stenosis evaluation by Doppler ultrasound Adina Voiculescu, MD Interventional Nephrology Brigham and Women s Hospital Boston Instructor at Harvard Medical School Understand
More informationAPPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS
APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS Jolanta DADONIENE*, Alma CYPIENE**, Diana KARPEC***, Rita RUGIENE*, Sigita STROPUVIENE*, Aleksandras
More informationLong-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center
Original Reumatismo, 2012; 64 (3): 158-165 Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D Ascanio,
More informationMethodology used to develop new ACR-EULAR criteria. Disclosures. Objectives Guiding principles underlying methodology
Methodology used to develop new ACR-EULAR criteria Sindhu Johnson MD PhD Toronto Scleroderma Program University of Toronto Co-convenors Janet Pope Frank van den Hoogen Members Jaap Fransen Sindhu Johnson
More informationElements for a Public Summary
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology High blood pressure in lung vessels which carry blood away from the heart Several studies showed that spontaneous high blood pressure
More informationDoppler ultrasound measurements of renal functional reserve in healthy subjects.
Original papers Med Ultrason 2015, Vol. 17, no. 4, 464-468 DOI: Doppler ultrasound measurements of renal functional reserve in healthy subjects. Mehmet Zekai Pekkafalı, Kemal Kara Gulhane Military Medicine
More informationDuplex Ultrasound of the Renal Arteries. Duplex Ultrasound. In the Beginning
Duplex Ultrasound of the Renal Arteries DIMENSIONS IN HEART AND VASCULAR CARE 2013 PENN STATE HEART AND VASCULAR INSTITUTE ROBERT G. ATNIP MD PROFESSOR OF SURGERY AND RADIOLOGY Duplex Ultrasound Developed
More informationDisorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome.
Disorders of the kidney. Urine analysis. Nephrotic and nephritic syndrome. Azotemia and Urinary Abnormalities Disturbances in urine volume oliguria, anuria, polyuria Abnormalities of urine sediment red
More informationRheumatology. Semaphorin 3A: an immunoregulator in systemic sclerosis
DOI 10.1007/s00296-015-3269-2 Rheumatology INTERNATIONAL SHORT COMMUNICATION - PATHOLOGY REVIEWS Semaphorin 3A: an immunoregulator in systemic sclerosis Doron Rimar 1 Yuval Nov 2 Itzhak Rosner 1 Gleb Slobodin
More informationDevelopment of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.
Development of SLE among Patients Seen in Consultation: Long-Term Follow-Up Abstract # 1699 May Al Daabil, MD Bonnie L. Bermas, MD Alexander Fine Hsun Tsao Patricia Ho Joseph F. Merola, MD Peter H. Schur,
More informationImage Formation (10) 2 Evaluation and Selection of Representative Images (10)
STRUCTURED SELF ASSESSMENT CONTENT SPECIFICATIONS SSA LAUNCH DATE: JANUARY 1, 2018 Vascular Sonography The purpose of continuing qualifications requirements (CQR) is to assist registered technologists
More information9/15/11. Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September Scleroderma. Hard skin
Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September 2011 Scleroderma Hard skin 1 No diagnostic test for scleroderma Pathogenesis is unknown prominent features of disease reflect
More informationTHE KIDNEY AND SLE LUPUS NEPHRITIS
THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationAlteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis A. Della Rossa 1, M. Cazzato 1, A. d Ascanio 1, A. Tavoni 2, W. Bencivelli 2, P.
More informationNOT COPY. Choice of the primary outcome: Pro Lung 03/09/2018. Lung assessment in clinical trials
Choice of the primary outcome: Pro Lung Christopher P. Denton Professor of Experimental Rheumatology Royal Free Hospital and University College London, UK Florence 7 th September 218 Improved clinical
More informationTitle. CitationJournal of medical ultrasonics, 44(4): Issue Date Doc URL. Rights. Type. File Information.
Title Altered oscillation of Doppler-derived renal and ren patients Kudo, Yusuke; Mikami, Taisei; Nishida, Mutsumi; Okad Author(s) Satomi; Shibuya, Hitoshi; Kahata, Kaoru; Shimizu, Ch CitationJournal of
More informationRenal Doppler Diagnostics in Lead-, Nickel- and Manganese-Exposed Children
666 Renal Doppler Diagnostics in Lead-, Nickel- and Manganese-Exposed Children Nina Zaitseva 1, Olga Ustinova 2, Olga Vozgoment 3, Alfiya Aminova 4 *, Alevtina Akatova 5, Yuliya Perlova 6, Irina Shtina
More informationGuillén-Del-Castillo et al. Arthritis Research & Therapy (2018) 20:281
Guillén-Del-Castillo et al. Arthritis Research & Therapy (2018) 20:281 https://doi.org/10.1186/s13075-018-1775-9 RESEARCH ARTICLE Open Access Quantitative videocapillaroscopy correlates with functional
More informationOptimising your Doppler settings for an accurate PI. Alison McGuinness Mid Yorks Hospitals
Optimising your Doppler settings for an accurate PI Alison McGuinness Mid Yorks Hospitals Applications Both maternal uterine and fetal circulations can be studied with doppler sonography Uterine arteries
More informationClinical Investigations
Clinical Investigations Right Ventricular Systolic Pressure Assessed by Echocardiography: A Predictive Factor of Mortality in Patients With Scleroderma Address for correspondence: Songsak Kiatchoosakun,
More informationPrevalence of pulmonary hypertension in systemic sclerosis and it s correlation with clinical variables
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 9 Ver. X (September. 2017), PP 90-95 www.iosrjournals.org Prevalence of pulmonary hypertension
More informationConcise report. Calcinosis in systemic sclerosis: subsets, distribution and complications RHEUMATOLOGY
RHEUMATOLOGY Rheumatology 2016;55:1610 1614 doi:10.1093/rheumatology/kew193 Advance Access publication 30 May 2016 CLINICAL SCIENCE Concise report Calcinosis in systemic sclerosis: subsets, distribution
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationReview Article Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects
International Rheumatology Volume 2010, Article ID 708067, 5 pages doi:10.1155/2010/708067 Review Article Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects Antonio Aversa,
More informationSambataro et al. Arthritis Research & Therapy 2014, 16:462
Sambataro et al. Arthritis Research & Therapy 2014, 16:462 RESEARCH ARTICLE Open Access Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady
More informationStages of Chronic Kidney Disease (CKD)
Early Treatment is the Key Stages of Chronic Kidney Disease (CKD) Stage Description GFR (ml/min/1.73 m 2 ) >90 1 Kidney damage with normal or GFR 2 Mild decrease in GFR 60-89 3 Moderate decrease in GFR
More informationS ystemic sclerosis (SSc) affects the skin and impairs the
682 EXTENDED REPORT Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement R Livi, L Teghini, A Pignone, S Generini, M Matucci-Cerinic, M
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES
Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel
More informationVascular Sonography Examination
Vascular Sonography Examination The purpose of The American Registry of Radiologic Technologists (ARRT ) Vascular Sonography Examination is to assess the knowledge and cognitive skills underlying the intelligent
More informationMESENTERIC ISCHEMIA. Phillip J Bendick, PhD
MESENTERIC ISCHEMIA Phillip J Bendick, PhD Arterial Celiac - Hepatic - Splenic Superior Mesenteric Artery Inferior Mesenteric Artery Venous Mesenteric system Porto - hepatic system Inferior Vena Cava Acute
More informationImproving the Detection of Pulmonary Hypertension in Systemic Sclerosis Using Pulmonary Function Tests
ARTHRITIS & RHEUMATISM Vol. 63, No. 11, November 2011, pp 3531 3539 DOI 10.1002/art.30535 2011, American College of Rheumatology Improving the Detection of Pulmonary Hypertension in Systemic Sclerosis
More informationHYPERTENSIVE VASCULAR DISEASE
HYPERTENSIVE VASCULAR DISEASE Cutoffs in diagnosing hypertension in clinical practice sustained diastolic pressures >90 mm Hg, or sustained systolic pressures >140 mm Hg Malignant hypertension A small
More informationMore severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis?
More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? V. Riccieri, V. Germano, C. Alessandri, M. Vasile, F.
More informationWhat effects will proximal or distal disease have on a waveform?
Spectral Doppler Interpretation Director of Ultrasound Education & Quality Assurance Baylor College of Medicine Division of Maternal-Fetal Medicine Maternal Fetal Center Imaging Manager Texas Children
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More informationImpact of Sickle Cell Disease in Renal Arteries Blood Flow Indices Using Ultrasonography
International Journal of Medical Imaging 2017; 5(2): 9-13 http://www.sciencepublishinggroup.com/j/ijmi doi: 10.11648/j.ijmi.20170502.11 ISSN: 2330-8303 (Print); ISSN: 2330-832X (Online) Impact of Sickle
More informationPulmonary Arterial Hypertension in systemic sclerosis
Pulmonary Arterial Hypertension in systemic sclerosis From the 3 rd Alpe Adria Meeting on Pulmonary Hypertension - Focus on Scleroderma October 5-6, 2012, Opatija, Croatia by Norbert Hasenoehrl Medical
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationMortality and prognostic factors in Spanish patients with systemic sclerosis
Rheumatology 2003;42:71 75 doi:10.1093/rheumatology/keg033, available online at www.rheumatology.oupjournals.org Mortality and prognostic factors in Spanish with systemic sclerosis C. P. Simeón, L. Armadans
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationBoin et al. Orphanet Journal of Rare Diseases 2014, 9:123
Boin et al. Orphanet Journal of Rare Diseases 2014, 9:123 LETTER TO THE EDITOR Open Access Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationA Comparison Between Anti-Th/To and Anticentromere Antibody Positive Systemic Sclerosis Patients With Limited Cutaneous Involvement
ARTHRITIS & RHEUMATISM Vol. 48, No. 1, January 2003, pp 203 209 DOI 10.1002/art.10760 2003, American College of Rheumatology A Comparison Between and Anticentromere Antibody Positive Systemic Sclerosis
More informationCarotid intima media thickness as an usefull tool in predicting cerebrovaskular events
Carotid intima media thickness as an usefull tool in predicting cerebrovaskular events Poster No.: C-0005 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit A. Rahimic - Catic; Sarajevo/BA
More informationDigital ulcers in scleroderma patients: A retrospective observational study
606846IJI0010.1177/0394632015606846International Journal of Immunopathology and PharmacologyDe Cata et al. research-article2015 Original article Digital ulcers in scleroderma patients: A retrospective
More informationSome renal vascular disorders
Some renal vascular disorders Introduction Nearly all diseases of the kidney involve the renal blood vessels secondarily We will discuss: -Hypertension (arterionephrosclerosis in benign HTN & hyperplastic
More information